| Lactose (India) Ltd | 126 Cr. | 100 | 205/84.3 | 27.9 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.21 Cr. | 1.68 | 4.29/1.68 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 3,920 Cr. | 360 | 479/192 | 81.2 | 24.3 | 0.19 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.6 Cr. | 45.3 | 87.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 57.7 Cr. | 39.4 | 41.0/17.0 | 137 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 73.4 Cr. | 97.5 | 119/69.7 | 19.8 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 56,155 Cr. | 1,990 | 2,286/1,275 | 22.3 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 315 Cr. | 13.0 | 17.2/10.8 | 18.9 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 17.0/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 813 Cr. | 1,515 | 1,999/635 | 28.1 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 94.5 Cr. | 18.9 | 32.0/17.0 | 25.8 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 996 Cr. | 338 | 449/219 | 8.89 | 133 | 0.74 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 2.92 Cr. | 13.9 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.42 Cr. | 2.98 | 8.28/2.11 | 4.22 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 420 Cr. | 432 | 536/211 | 63.4 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,216 Cr. | 1,201 | 1,565/944 | 47.2 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 49.1 Cr. | 0.24 | 1.12/0.23 | 3.23 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 41.9 Cr. | 15.9 | 26.3/11.4 | 20.4 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 8.22 Cr. | 8.13 | 15.8/8.01 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 161 Cr. | 450 | 851/419 | 9.10 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 81.9 Cr. | 81.9 | 92.5/26.1 | 154 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 13,707 Cr. | 1,307 | 2,452/1,292 | 42.6 | 174 | 0.82 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 23.2 Cr. | 50.7 | 88.7/36.1 | 50.4 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 12.3 Cr. | 4.92 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 21.3 Cr. | 142 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 70.6 Cr. | 129 | 144/9.41 | 48.7 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 29.6 Cr. | 39.2 | 73.0/33.0 | 47.7 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.44 Cr. | 21.4 | 24.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 8,337 Cr. | 480 | 1,028/472 | 23.7 | 72.4 | 0.25 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 78.6 Cr. | 18.2 | 29.6/17.9 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.6 Cr. | 22.9 | 43.0/17.4 | 50.5 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 87,369 Cr. | 2,117 | 2,755/2,090 | 52.4 | 376 | 0.05 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 233 Cr. | 405 | 524/241 | 23.9 | 123 | 1.11 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 64.4 Cr. | 44.9 | 47.9/26.7 | 101 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 67,838 Cr. | 1,168 | 1,279/994 | 19.8 | 603 | 0.34 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 140 Cr. | 225 | 303/159 | 134 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 735 Cr. | 73.2 | 115/73.0 | 19.0 | 32.6 | 2.05 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 31.4 Cr. | 24.0 | 44.6/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,796 Cr. | 1,682 | 1,902/919 | 61.6 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.36 Cr. | 0.66 | 1.19/0.51 | 109 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 53.8/26.0 | 13.0 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 6.86 Cr. | 11.7 | 20.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 130 Cr. | 5.51 | 6.57/2.82 | 302 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 58,922 Cr. | 27,750 | 37,000/25,260 | 39.0 | 1,888 | 1.71 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 7,036 Cr. | 777 | 972/557 | 29.4 | 226 | 0.64 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 178 Cr. | 62.7 | 100/31.3 | 49.6 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,295 Cr. | 1,295 | 1,740/752 | | 103 | 0.08 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,009 Cr. | 1,418 | 1,870/1,110 | 419 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 734 Cr. | 212 | 330/154 | 17.1 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 67.8 Cr. | 8.16 | 29.4/8.14 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 987 Cr. | 760 | 849/270 | 15.6 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,783 Cr. | 397 | 791/396 | 19.1 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,417 Cr. | 1,004 | 1,402/975 | 20.1 | 768 | 1.00 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,38,290 Cr. | 4,087 | 4,108/2,886 | 63.8 | 250 | 0.78 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 808 Cr. | 88.0 | 272/87.3 | | 41.3 | 0.57 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,190 Cr. | 12.7 | 23.5/12.6 | 18.9 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 15,989 Cr. | 418 | 1,328/414 | 46.6 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,422 Cr. | 150 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,01,912 Cr. | 1,675 | 1,851/1,547 | 34.8 | 324 | 0.95 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,372 Cr. | 532 | 734/441 | 370 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,943 Cr. | 314 | 360/175 | 36.3 | 81.2 | 0.13 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,648 Cr. | 290 | 502/265 | 36.5 | 125 | 0.17 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,976 Cr. | 206 | 260/111 | 208 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,396 Cr. | 4,074 | 6,718/4,017 | 25.4 | 340 | 2.87 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,798 Cr. | 2,294 | 2,725/1,772 | 34.1 | 335 | 0.87 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,097 Cr. | 5,443 | 6,739/4,904 | 29.6 | 373 | 2.30 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 164 Cr. | 46.6 | 77.4/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,492 Cr. | 4,694 | 5,993/3,701 | 30.4 | 841 | 0.75 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 113 Cr. | 91.5 | 206/81.0 | 11.6 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,393 Cr. | 392 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,615 Cr. | 712 | 1,670/604 | 69.2 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 17,854 Cr. | 13,899 | 19,748/10,060 | 91.2 | 1,263 | 0.09 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 320 Cr. | 14.4 | 41.0/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 15,138 Cr. | 846 | 1,341/660 | 9.84 | 483 | 0.71 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,021 Cr. | 36.9 | 71.3/36.8 | 26.8 | 21.8 | 0.54 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 7,859 Cr. | 173 | 276/162 | 22.4 | 59.3 | 0.46 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 77.9 Cr. | 49.4 | 123/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 267 Cr. | 75.5 | 164/72.2 | 131 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 99,525 Cr. | 2,177 | 2,228/1,774 | 23.0 | 430 | 0.55 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 930 Cr. | 464 | 820/460 | 11.6 | 357 | 0.39 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 57,395 Cr. | 1,063 | 1,141/501 | 84.1 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,114 Cr. | 1,074 | 1,235/596 | 22.7 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 138 Cr. | 63.5 | 114/60.4 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 689 Cr. | 143 | 216/123 | 39.1 | 104 | 2.10 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 594 Cr. | 338 | 500/265 | 21.5 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 15,826 Cr. | 994 | 1,250/802 | 31.8 | 414 | 0.50 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 30,221 Cr. | 1,927 | 1,939/1,303 | 40.1 | 243 | 0.80 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,168 Cr. | 174 | 302/173 | 26.7 | 38.0 | 1.43 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 37,753 Cr. | 1,487 | 1,599/1,168 | 38.1 | 293 | 0.27 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,191 Cr. | 74.5 | 127/57.5 | 18.9 | 59.7 | 1.07 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 27.6/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 911 Cr. | 111 | 124/67.2 | 30.7 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 1,976 Cr. | 214 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,617 Cr. | 212 | 457/207 | 259 | 96.9 | 0.66 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,249 Cr. | 1,463 | 2,350/1,243 | 28.5 | 397 | 0.48 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,152 Cr. | 313 | 470/285 | 58.0 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,965 Cr. | 574 | 627/412 | 27.3 | 164 | 0.26 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 56,155 Cr. | 1,990 | 2,286/1,275 | 22.3 | 340 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 39,409 Cr. | 2,330 | 3,516/1,921 | 41.3 | 101 | 1.80 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,693 Cr. | 1,681 | 2,131/1,200 | 24.0 | 610 | 1.07 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,346 Cr. | 389 | 528/359 | 28.2 | 149 | 1.28 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 19,693 Cr. | 1,444 | 1,910/1,097 | 47.4 | 227 | 0.51 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 97,414 Cr. | 1,167 | 1,380/1,020 | 16.9 | 432 | 0.69 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,830 Cr. | 244 | 322/178 | 25.6 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,12,430 Cr. | 1,392 | 1,673/1,310 | 20.7 | 408 | 0.93 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,795 Cr. | 1,812 | 2,397/1,551 | 23.4 | 416 | 0.33 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 199 Cr. | 68.1 | 174/66.0 | 14.3 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,737 Cr. | 164 | 196/105 | 15.8 | 107 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 52.4 Cr. | 32.2 | 59.0/30.3 | 18.4 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 56,732 Cr. | 376 | 425/291 | 120 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,564 Cr. | 1,549 | 2,000/1,430 | 34.6 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 112 Cr. | 70.8 | 129/67.2 | 16.4 | 49.2 | 1.70 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 284 Cr. | 122 | 205/67.8 | 26.9 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 20,775 Cr. | 8,298 | 10,691/6,502 | 89.9 | 320 | 0.39 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,766 Cr. | 611 | 791/544 | 31.2 | 118 | 0.75 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 143 Cr. | 68.6 | 137/68.2 | 7.59 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,741 Cr. | 5,748 | 5,934/4,492 | 29.2 | 1,116 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 15,124 Cr. | 770 | 1,108/725 | 23.8 | 271 | 1.43 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 391 Cr. | 689 | 1,251/685 | | 690 | 0.73 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 33,560 Cr. | 2,686 | 3,080/2,022 | 34.5 | 345 | 1.04 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,082 Cr. | 276 | 367/258 | 20.9 | 133 | 1.89 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,428 Cr. | 376 | 575/312 | 18.0 | 147 | 0.27 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 19,907.60 Cr | 1,108.76 | | 52.02 | 202.18 | 0.37% | 16.29% | 15.20% | 6.10 |